All over the world there are strict restrictions for aviation and transport during the ongoing pandemic. The Air Alliance Medflight are considered humanitarian, and can still operate on most airports. However, overnight stays and quarantine rules has changed the workflow.
“The restrictions have become a big challenge, and is often very time consuming. Luckily, our crew and medical staff are well trained for different scenarios. Even in harsh weather and difficult situations, we are able to operate safely and give our patients the support and treatment they need during the flight”, says Eva Kluge, Chief Commercial Officer, in Air Alliance Medflight.
In 2020, EpiGuard, the Norwegian company behind EpiShuttle, has produced more than 200 units of the isolation pod. The EpiShuttle provides a completely sealed barrier between an infectious patient and the surrounding environment, protecting both craft and professionals. At the same time, it allows patient monitoring and full intensive care treatment during transport, including emergency procedures like intubation and insertion of central venous catheters. It is cost-efficient and can be re-used for next mission.
“The EpiShuttle make transport safe, reduce cost and increase operational efficiency. An ambulance usually requires 2-4 hours of disinfection between every contagious transport, and with an entire aircraft like the Challenger 604, it takes almost a day. Collaborating with partners as Air Alliance gives us important insight for developing Epishuttle further”, says Ellen Cathrine Andersen, CEO of EpiGuard.